Pericyazine: Difference between revisions
From SEHK Wiki
No edit summary |
|||
| Line 48: | Line 48: | ||
|- | |- | ||
!style="text-align: left"| Short-term adjunctive management of severe anxiety, and violent or dangerously impulse behaviour | !style="text-align: left"| Short-term adjunctive management of severe anxiety, and violent or dangerously impulse behaviour | ||
By ''mouth | |By ''mouth | ||
ADULT: | ADULT: | ||
*15-30 mg daily in 2 divided doses | *15-30 mg daily in 2 divided doses | ||
Revision as of 22:01, 21 October 2020
Pericyazine(中文:[[ ]]) is a typical antipsychotic medication. Periciazine is indicated:
- In adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse.
- As a short-term adjuntive management of severe anxiety, and violent or dangerously impulseive behavior.
Periciazine is not recommended for children.
Pronunciation
Pericyazine 10mg
Pericyazine 2.5mg
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Pericyazine Tab 2.5 mg | PERI01 | P1S1S3 |
| Pericyazine Tab 10 mg | PERI02 | P1S1S3 |
Mechanism of Action
Pericyazine is presumed to act primarily in the subcortical areas, by blocking central alpha-adrenergic receptors and the D1 dopamine receptor. The presumed effectiveness of antipsychotic drugs relied on their ability to block dopamine receptors. This assumption arose from the dopamine hypothesis that maintains that both schizophrenia and bipolar disorder are a result of excessive dopamine activity.
Dosage
| Indication | Dose |
|---|---|
| Schizophrenia and other psychoses | By mouth
ADULT:
ELDERLY or debilitated patients:
|
| Short-term adjunctive management of severe anxiety, and violent or dangerously impulse behaviour | By mouth
ADULT:
ELDERLY or debilitated patients:
|
